Inhibition of metastatic potential in breast carcinoma in vivo and in vitro through targeting VEGFRs and FGFRs

Ming Hsien Chien, Liang Ming Lee, Michael Hsiao, Lin Hung Wei, Chih Hau Chen, Tsung Ching Lai, Kuo Tai Hua, Min Wei Chen, Chung Ming Sun, Min Liang Kuo

研究成果: 雜誌貢獻文章

6 引文 (Scopus)

摘要

Angiogenesis and lymphangiogenesis are considered to play key roles in tumor metastasis. Targeting receptor tyrosine kinases essentially involved in the angiogenesis and lymphangiogenesis would theoretically prevent cancer metastasis. However, the optimal multikinase inhibitor for metastasis suppression has yet to be developed. In this study, we evaluated the effect of NSTPBP 0100194-A (194-A), a multikinase inhibitor of vascular endothelial growth factor receptors (VEGFRs)/fibroblast growth factor receptors (FGFRs), on lymphangiogenesis and angiogenesis in a mammary fat pad xenograft model of the highly invasive breast cancer cell line 4T1-Luc+. We investigated the biologic effect of 194-A on various invasive breast cancer cell lines as well as endothelial and lymphatic endothelial cells. Intriguingly, we found that 194-A drastically reduced the formation of lung, liver, and lymph node metastasis of 4T1-Luc+ and decreased primary tumor growth. This was associated with significant reductions in intratumoral lymphatic vessel length (LVL) and microvessel density (MVD). 194-A blocked VEGFRs mediated signaling on both endothelial and lymphatic endothelial cells. Moreover, 194-A significantly inhibited the invasive capacity induced by VEGF-C or FGF-2 in vitro in both 4T1 and MDA-MB231 cells. In conclusion, these experimental results demonstrate that simultaneous inhibition of VEGFRs/FGFRs kinases may be a promising strategy to prevent breast cancer metastasis.
原文英語
文章編號718380
期刊Evidence-based Complementary and Alternative Medicine
2013
DOIs
出版狀態已發佈 - 2013

指紋

Fibroblast Growth Factor Receptors
Vascular Endothelial Growth Factor Receptor
Lymphangiogenesis
Breast Neoplasms
Neoplasm Metastasis
Endothelial Cells
Vascular Endothelial Growth Factor C
Cell Line
Neoplasms
Lymphatic Vessels
Receptor Protein-Tyrosine Kinases
Fibroblast Growth Factor 2
Microvessels
Heterografts
Adipose Tissue
Breast
Phosphotransferases
Lymph Nodes
In Vitro Techniques
Lung

ASJC Scopus subject areas

  • Complementary and alternative medicine

引用此文

Inhibition of metastatic potential in breast carcinoma in vivo and in vitro through targeting VEGFRs and FGFRs. / Chien, Ming Hsien; Lee, Liang Ming; Hsiao, Michael; Wei, Lin Hung; Chen, Chih Hau; Lai, Tsung Ching; Hua, Kuo Tai; Chen, Min Wei; Sun, Chung Ming; Kuo, Min Liang.

於: Evidence-based Complementary and Alternative Medicine, 卷 2013, 718380, 2013.

研究成果: 雜誌貢獻文章

Chien, Ming Hsien ; Lee, Liang Ming ; Hsiao, Michael ; Wei, Lin Hung ; Chen, Chih Hau ; Lai, Tsung Ching ; Hua, Kuo Tai ; Chen, Min Wei ; Sun, Chung Ming ; Kuo, Min Liang. / Inhibition of metastatic potential in breast carcinoma in vivo and in vitro through targeting VEGFRs and FGFRs. 於: Evidence-based Complementary and Alternative Medicine. 2013 ; 卷 2013.
@article{b83cd9c77b08435199c99aaef7422a0d,
title = "Inhibition of metastatic potential in breast carcinoma in vivo and in vitro through targeting VEGFRs and FGFRs",
abstract = "Angiogenesis and lymphangiogenesis are considered to play key roles in tumor metastasis. Targeting receptor tyrosine kinases essentially involved in the angiogenesis and lymphangiogenesis would theoretically prevent cancer metastasis. However, the optimal multikinase inhibitor for metastasis suppression has yet to be developed. In this study, we evaluated the effect of NSTPBP 0100194-A (194-A), a multikinase inhibitor of vascular endothelial growth factor receptors (VEGFRs)/fibroblast growth factor receptors (FGFRs), on lymphangiogenesis and angiogenesis in a mammary fat pad xenograft model of the highly invasive breast cancer cell line 4T1-Luc+. We investigated the biologic effect of 194-A on various invasive breast cancer cell lines as well as endothelial and lymphatic endothelial cells. Intriguingly, we found that 194-A drastically reduced the formation of lung, liver, and lymph node metastasis of 4T1-Luc+ and decreased primary tumor growth. This was associated with significant reductions in intratumoral lymphatic vessel length (LVL) and microvessel density (MVD). 194-A blocked VEGFRs mediated signaling on both endothelial and lymphatic endothelial cells. Moreover, 194-A significantly inhibited the invasive capacity induced by VEGF-C or FGF-2 in vitro in both 4T1 and MDA-MB231 cells. In conclusion, these experimental results demonstrate that simultaneous inhibition of VEGFRs/FGFRs kinases may be a promising strategy to prevent breast cancer metastasis.",
author = "Chien, {Ming Hsien} and Lee, {Liang Ming} and Michael Hsiao and Wei, {Lin Hung} and Chen, {Chih Hau} and Lai, {Tsung Ching} and Hua, {Kuo Tai} and Chen, {Min Wei} and Sun, {Chung Ming} and Kuo, {Min Liang}",
year = "2013",
doi = "10.1155/2013/718380",
language = "English",
volume = "2013",
journal = "Evidence-based Complementary and Alternative Medicine",
issn = "1741-427X",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Inhibition of metastatic potential in breast carcinoma in vivo and in vitro through targeting VEGFRs and FGFRs

AU - Chien, Ming Hsien

AU - Lee, Liang Ming

AU - Hsiao, Michael

AU - Wei, Lin Hung

AU - Chen, Chih Hau

AU - Lai, Tsung Ching

AU - Hua, Kuo Tai

AU - Chen, Min Wei

AU - Sun, Chung Ming

AU - Kuo, Min Liang

PY - 2013

Y1 - 2013

N2 - Angiogenesis and lymphangiogenesis are considered to play key roles in tumor metastasis. Targeting receptor tyrosine kinases essentially involved in the angiogenesis and lymphangiogenesis would theoretically prevent cancer metastasis. However, the optimal multikinase inhibitor for metastasis suppression has yet to be developed. In this study, we evaluated the effect of NSTPBP 0100194-A (194-A), a multikinase inhibitor of vascular endothelial growth factor receptors (VEGFRs)/fibroblast growth factor receptors (FGFRs), on lymphangiogenesis and angiogenesis in a mammary fat pad xenograft model of the highly invasive breast cancer cell line 4T1-Luc+. We investigated the biologic effect of 194-A on various invasive breast cancer cell lines as well as endothelial and lymphatic endothelial cells. Intriguingly, we found that 194-A drastically reduced the formation of lung, liver, and lymph node metastasis of 4T1-Luc+ and decreased primary tumor growth. This was associated with significant reductions in intratumoral lymphatic vessel length (LVL) and microvessel density (MVD). 194-A blocked VEGFRs mediated signaling on both endothelial and lymphatic endothelial cells. Moreover, 194-A significantly inhibited the invasive capacity induced by VEGF-C or FGF-2 in vitro in both 4T1 and MDA-MB231 cells. In conclusion, these experimental results demonstrate that simultaneous inhibition of VEGFRs/FGFRs kinases may be a promising strategy to prevent breast cancer metastasis.

AB - Angiogenesis and lymphangiogenesis are considered to play key roles in tumor metastasis. Targeting receptor tyrosine kinases essentially involved in the angiogenesis and lymphangiogenesis would theoretically prevent cancer metastasis. However, the optimal multikinase inhibitor for metastasis suppression has yet to be developed. In this study, we evaluated the effect of NSTPBP 0100194-A (194-A), a multikinase inhibitor of vascular endothelial growth factor receptors (VEGFRs)/fibroblast growth factor receptors (FGFRs), on lymphangiogenesis and angiogenesis in a mammary fat pad xenograft model of the highly invasive breast cancer cell line 4T1-Luc+. We investigated the biologic effect of 194-A on various invasive breast cancer cell lines as well as endothelial and lymphatic endothelial cells. Intriguingly, we found that 194-A drastically reduced the formation of lung, liver, and lymph node metastasis of 4T1-Luc+ and decreased primary tumor growth. This was associated with significant reductions in intratumoral lymphatic vessel length (LVL) and microvessel density (MVD). 194-A blocked VEGFRs mediated signaling on both endothelial and lymphatic endothelial cells. Moreover, 194-A significantly inhibited the invasive capacity induced by VEGF-C or FGF-2 in vitro in both 4T1 and MDA-MB231 cells. In conclusion, these experimental results demonstrate that simultaneous inhibition of VEGFRs/FGFRs kinases may be a promising strategy to prevent breast cancer metastasis.

UR - http://www.scopus.com/inward/record.url?scp=84879294018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879294018&partnerID=8YFLogxK

U2 - 10.1155/2013/718380

DO - 10.1155/2013/718380

M3 - Article

C2 - 23861711

AN - SCOPUS:84879294018

VL - 2013

JO - Evidence-based Complementary and Alternative Medicine

JF - Evidence-based Complementary and Alternative Medicine

SN - 1741-427X

M1 - 718380

ER -